AB Klaipėdos nafta (KN) will hold an Investor Conference

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
52
AB Klaipėdos nafta (KN) will hold an Investor Conference Webinar to introduce the financial results for the first quarter of 2017

KN invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the April 28, 2017 at 9 am (EET). The presentation will be held in English.

The webinar will be hosted by KN General Manager Mindaugas Jusius and Director of Finance and Administration Department Marius Pulkauninkas who will introduce the Company’s financial results for the first quarter of 2017 and will answer the participant questions.

After the presentation investors are welcome to ask questions. Due to limited webinar time, we encourage participants to send their questions before the webinar until April 27th to simona.backiene@nasdaq.com

How to join the webinar?

To join the webinar, please register via following link: https://attendee.gotowebinar.com/register/137...9540873474 You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will be asked to download the plug-in which will take only few seconds. In case plug-in can't be downloaded, a web browser which enables attending the webinar, opens automatically. The webinar will be recorded and available online for everyone at the company’s website on www.kn.lt and on Nasdaq Baltic youtube.com account.

What is a corporate webinar?

A corporate webinar is a virtual conference, during which company’s representatives provide information about the company and its performance. Webinar allows interactive communication and a possibility to ask questions and get answers directly from the company while being located anywhere.

         Indrė Milinienė, Chief Communications Officer, tel.: 8 46 391 772

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading